Jl. Pollock et Hw. Virgin, LATENCY, WITHOUT PERSISTENCE, OF MURINE CYTOMEGALOVIRUS IN THE SPLEENAND KIDNEY, Journal of virology, 69(3), 1995, pp. 1762-1768
It is not known if murine cytomegalovirus (MCMV) establishes a state o
f molecular latency independent of low-level persistent infection. The
presence of low levels of infectious MCMV distinguishes persistence f
rom molecular latency, Thus, the distinction between persistence and l
atency has depended on the sensitivity of plaque assays for detecting
low levels of infectious virus in tissue of previously infected mice.
To determine whether MCMV establishes molecular latency or remains per
sistent; we developed two assays for detecting low levels of MCMV in t
issue. Using prolonged in vitro culture of virus with either mouse emb
ryonic fibroblasts or the murine 3T12 fibroblast cell line, we reprodu
cibly detected a single PFU of MCMV, Inclusion of undiluted sonicated
tissue in this assay decreased sensitivity by up to 100-fold. However,
sensitivity was improved to 1 PFU of MCMV when sonicated tissue was a
ppropriately diluted, Severe combined immunodeficient (SCID) mice were
also used to detect MCMV in sonicated tissue, Infection of SCID mice
with a single PFU of MCMV killed two of eight SCID mice, and the 50% l
ethal dose of MCMV in SCID mice was 2 to 3 PFU, Applying these two met
hods, we detected infectious virus in 0 of 34 spleens, 1 of 34 kidneys
, and 0 of 37 salivary glands from latently infected mice. Spleens and
kidneys assessed for persistent virus contained MCMV DNA by PCR and r
eactivated after 10 to 50 days in explant cultures. Latently infected
kidney cells reactivated after adoptive transfer to SCID mice. Quantit
ation of the MCMV genome by PCR showed that latently infected spleens
without detectable infectious MCMV contained about 3,000,000 copies of
the MCMV genome. These results demonstrate that MCMV latency in splee
n and kidney exists in the absence of low-level persistent infection.
Use of assays with defined sensitivity for detection of MCMV in tissue
provides a basis for evaluation of cytomegalovirus gene expression in
the spleen and kidney during molecular latency.